Browsing by Yonsei Author : Kim, Do Young

eperson profile image
Name:
Kim, Do Young [김도영]
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (56119929100)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 474

This table browses all dspace content
Issue DateTitleJournal Title
2024Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study LIVER CANCER
2024Correspondence to editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/ bevacizumab failure: A real-world study” CLINICAL AND MOLECULAR HEPATOLOGY
2024Intraindividual comparison of prognostic imaging features of HCCs between MRIs with extracellular and hepatobiliary contrast agentsLIVER INTERNATIONAL
2024Regulation of Tumor Microenvironment through YAP/TAZ under Tumor Hypoxia CANCERS
2024Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma YONSEI MEDICAL JOURNAL
2024Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study CLINICAL AND MOLECULAR HEPATOLOGY
2024Liver-Directed Combined Radiation Therapy for Downstaging Beyond-Milan Hepatocellular Carcinoma to Liver TransplantationINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2024Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma: A phase II studyJOURNAL OF HEPATOLOGY
2024Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic centerJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2024Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s diseaseEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2024Machine learning-based clinical decision support system for treatment recommendation and overall survival prediction of hepatocellular carcinoma: a multi-center study NPJ DIGITAL MEDICINE(Nature partner journals digital medicine Digital medicine)
2024Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea GUT AND LIVER
2023Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center Study CANCERS
2023Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma CELL COMMUNICATION AND SIGNALING
2023MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide studyJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2023ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related CirrhosisCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2023Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus-related liver cirrhosisJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2023A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis BLIVER INTERNATIONAL
2023A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoneAMERICAN JOURNAL OF GASTROENTEROLOGY
2023Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study CLINICAL AND MOLECULAR HEPATOLOGY
2023Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis CLINICAL AND MOLECULAR HEPATOLOGY
2023Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association-National Cancer Center 2022 Criteria CANCER RESEARCH AND TREATMENT
2023The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNAJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2023Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region CLINICAL AND MOLECULAR HEPATOLOGY
2023Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma CLINICAL AND MOLECULAR HEPATOLOGY
2023Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver diseaseLIVER INTERNATIONAL
2023Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment CANCER MEDICINE
2023Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinomaEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2023Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis DIAGNOSTICS
2023Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel DiseGUT AND LIVER
2022Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology Journal of Liver Cancer(대한간암학회지)
2022Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease GUT AND LIVER
2022Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model GASTROENTEROLOGY REPORT
2022Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis BDIGESTIVE DISEASES AND SCIENCES
2022A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid-Enhanced MRI FeaturesJOURNAL OF MAGNETIC RESONANCE IMAGING
2022Total Lesion Glycolysis on 18F-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on 90Y PET/CT in Patients With Hepatocellular Carcinoma Treated With 90Y Transarterial RadioembolizationCLINICAL NUCLEAR MEDICINE
2022Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of LobeglitazoneCLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT
2022Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling studyLANCET GASTROENTEROLOGY & HEPATOLOGY
2022Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS) CANCERS
2022Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis CANCERS
2022Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways BMC CANCER
2022Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria FRONTIERS IN MEDICINE
2022Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis BCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2022Cost-effectiveness of chronic hepatitis C screening and treatment CLINICAL AND MOLECULAR HEPATOLOGY
2022Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter studyJOURNAL OF VIRAL HEPATITIS
2022Expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2022A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients JOURNAL OF KOREAN MEDICAL SCIENCE
2022Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study CANCERS
2022Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease GUT AND LIVER
2022Liver-directed concurrent chemoradiotherapy versus sorafenib in hepatocellular carcinoma with portal vein tumor thrombusJOURNAL OF CLINICAL ONCOLOGY

Browse

Links